跳至主要内容
临床试验/NCT05463991
NCT05463991招募中不适用

Bioengineered Collagen Scaffold Implant as an Alternative to Conventional Buccal Mucosa for Substitution Urethroplasty of Distal Urethral Strictures. - A Pilot Stud

Regenosca SA2 个研究点 分布在 1 个国家目标入组 5 人开始时间: 2022年8月15日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
发起方
入组人数
5
试验地点
2
主要终点
Urethral patency

研究概览

简要总结

The field of research for this study is tissue engineering and the utilization of a bioengineered collagen implant as a substitute biomaterial for conventional buccal mucosa in substitution urethroplasty of distal urethral strictures.

详细描述

Urethral stricture is defined as the abnormal narrowing of the urethral lumen in the area of the corpus spongiosum. A stricture is the result of ischemic spongiofibrosis manifesting as scar tissue in the corpus spongiosum. Long-term consequences are chronic fistulation through the skin, recurrent sepsis, bladder stones, obstructive uropathy, obstructive nephropathy, and finally renal failure.

Current available surgical techniques for urethral stricture repair require harvesting of grafts from autologous sites resulting in additional risks of complications at the tissue harvest site and additional pain to the patient.

The hypothesis of this study is that the developed bioengineered collagen implant can be used as an alternative biomaterial to buccal mucosa for substitution urethroplasty in urethral stricture patients.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Device Feasibility
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
Male
接受健康志愿者

入选标准

  • Adult males with urethral stricture less than 3 cm (anywhere from penile to bulbar urethra not including the membranous urethra) with existing lumen of at least 6 Fr suitable for augmentation urethroplasty. The stricture may be due to trauma or infection.

排除标准

  • Known bovine collagen allergy
  • Current urinary tract infection
  • Chronic renal failure
  • Neurological diseases
  • Chronic obstructive pulmonary diseases
  • Sleep disturbances
  • Depression
  • Former cancer treatment
  • Recurrent stricture

结局指标

主要结局

Urethral patency

时间窗: four weeks post-surgery

A peri-urethrogram will be performed prior to catheter removal.

次要结局

  • Urine flow(two months up-to twenty-four months post-surgery)
  • Voiding symptoms(two months up-to twenty-four months post-surgery)

研究者

发起方
Regenosca SA
申办方类型
Industry
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验